% Generated by roxygen2: do not edit by hand
% Please edit documentation in R/get_titeboin_decision.R
\name{get_titeboin_decision}
\alias{get_titeboin_decision}
\title{Generate TITE-BOIN Decision Table}
\usage{
get_titeboin_decision(
  lambda_e,
  lambda_d,
  target,
  n_max,
  cohort_size = 3,
  max_accrual_pending_ratio = 0.51,
  v = 0.25,
  cutoff_eli = 0.95,
  neli = 3,
  prior_strength = 0.5
)
}
\arguments{
\item{lambda_e}{Lower boundary for dose escalation (from \code{get_boin_boundary()})}

\item{lambda_d}{Upper boundary for dose de-escalation (from \code{get_boin_boundary()})}

\item{target}{Target toxicity rate (e.g., 0.30 for 30\\%)}

\item{n_max}{Maximum number of patients in the trial}

\item{cohort_size}{Number of patients per cohort (default: 3)}

\item{max_accrual_pending_ratio}{Maximum allowable ratio of pending patients
before suspending accrual (default: 0.51, meaning suspend when >49\\% pending)}

\item{v}{Missing fraction threshold for decision rules (default: 0.25)}

\item{cutoff_eli}{Posterior probability cutoff for dose elimination (default: 0.95)}

\item{neli}{Minimum sample size required for dose elimination (default: 3)}

\item{prior_strength}{Prior strength parameter for toxicity rate estimation (default: 0.5)}
}
\value{
A data frame containing the TITE-BOIN decision table with columns:
\describe{
\item{n_patients}{Number of patients treated at the dose}
\item{n_tox}{Number of observed toxicities (completed assessments only)}
\item{n_pending}{Number of patients with pending toxicity assessments}
\item{suspend}{Accrual suspension condition}
\item{escalate}{Dose escalation condition}
\item{stay}{Stay at current dose condition}
\item{de_escalate}{Dose de-escalation condition}
}
}
\description{
Generate a comprehensive decision table for the Time-to-Event Bayesian Optimal
Interval (TITE-BOIN) design. The table contains dose escalation/de-escalation/stay
decisions based on the number of patients treated, observed toxicities, and
pending patients (those whose toxicity assessment is incomplete).

The decision rules incorporate three scenarios:
\itemize{
\item Rule 1: Accrual suspension when pending ratio is high and toxicity is low
\item Rule 2: Standard BOIN decisions when all patients have completed follow-up
\item Rule 3: Modified decisions accounting for pending patients using
Standardized Total Follow-up Time (STFT)
}
}
\details{
The TITE-BOIN design extends the standard BOIN design to handle late-onset
toxicities by making real-time decisions while some patients' toxicity outcomes
are still pending. The decision table uses the Standardized Total Follow-up Time
(STFT) to quantify the amount of follow-up information available from pending
patients.
}
\examples{
# Generate TITE-BOIN decision table for a trial with target DLT rate of 30\%
target <- 0.30
boundary <- get_boin_boundary(target)

decision_table <- get_titeboin_decision(
  lambda_e = boundary$lambda_e,
  lambda_d = boundary$lambda_d,
  target = target,
  n_max = 18,
  cohort_size = 3,
  max_accrual_pending_ratio = 0.51,
  cutoff_eli = 0.95
)

# View the first few rows
head(decision_table)

}
\references{
Yuan, Y., Lin, R., Li, D., Nie, L. and Warren, K.E. (2018).
Time-to-Event Bayesian Optimal Interval Design to Accelerate Phase I Trials.
Clinical Cancer Research, 24(20): 4921-4930.

Liu S. and Yuan, Y. (2015). Bayesian Optimal Interval Designs for Phase I
Clinical Trials. Journal of the Royal Statistical Society: Series C, 64, 507-523.
}
